Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
450 participants
OBSERVATIONAL
2021-12-01
2027-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Overview of the Mental Health of Adolescents in Therapeutci, Educational and Pedagogical Facilities in France
NCT06489912
National Investigation in College and High School Among Adolescents on Health and Substances at the FSEF
NCT05225441
Mental Health and Sexuality in Adolescents and Young Adults
NCT05316948
Clinical and Actigraphic Profile of Young Patients Admitted for Attempted Suicide
NCT02803632
At-risk Intervention and Mentoring Evaluation
NCT02174224
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Quality of life questionnaires
QOL to be completed by the participant
The scales (PUTS, OCI, TS-QOL, ASRS, GAD-7, PHQ9, TAPS) to be completed by the participant
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
QOL to be completed by the participant
The scales (PUTS, OCI, TS-QOL, ASRS, GAD-7, PHQ9, TAPS) to be completed by the participant
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients with Tic disorders
3. Given the non-opposition
1. No affiliation to a French health social insurance
2. Significant congenital disorders that may affect understanding of assessments
3. Patients under guardianship or curatorship
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Clermont-Ferrand
Clermont-Ferrand, , France
CHU Limoges
Limoges, , France
CHU Marseille
Marseille, , France
Service de Neurologie, GH Pitié Salpêtrière
Paris, , France
CHU Poitiers
Poitiers, , France
CHU Nantes
Saint-Herblain, , France
CHU Strasbourg
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APHP210801
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.